Newsroom
Amgen's Blinatumomab Receives Breakthrough Designation in ALL
Breakthrough Designation Reinforces Significant Unmet Need in the Treatment of This Highly Aggressive Cancer
UnitedHealth, an Insurer Switching Roles, Helps Hospitals on Medicare Billing
To hospitals, billions of dollars depend on how they define a patient’s stay.
Fee-For-Service Thwarts Value-Based Care's Intention
Society wants the healthcare system to improve the population's overall health while caring for the sick at a lower overall cost. The term of art is providing value-based care. Yet system leaders are stuck with a reimbursement system that still rewards volume through fee-for-service medicine.
CT Scan Could Double the Risk of Cancers in NHL Patients
Patients with non-Hodgkin's lymphoma who have received 8 or more CT scans have a 2-fold risk for secondary primary malignancies, new research shows.
AJMC Review of Specialty Pharmaceuticals Finds New Drugs Prove Their Value
Specialty pharmaceuticals are changing the lives of patients with cancer and chronic conditions, but their high cost and increased used has drawn the scrutiny of payers. A review in this month’s issue of The American Journal of Managed Care, which examined studies involving therapies for rheumatoid arthritis, multiple sclerosis, and breast cancer, found that when these drugs are used with the right patients, the value for patients is high.
CDC’s Michael Bell to Give Keynote at AJMC Infectious Disease Conference in Atlanta
The American Journal of Managed Care will host a two-day event September 25-26, 2014, in Atlanta taking on some of healthcare’s biggest challenges in infectious disease, including HIV, MERS and how to pay for new therapies for hepatitis C. Giving the keynote address will be Michael Bell, MD, deputy director of the Centers for Disease Control and Prevention’s Division of Healthcare Quality Promotion.
FDA Approves Inhaled Diabetes Medication
People with type 1 or 2 diabetes now have a new means of getting their medication, with the U.S. Food and Drug Administration's approval on Friday of the first inhaled medicine for the blood sugar disease.
Sunshine Act Exemption for CME Payments Could Shift Marketing
A CMS rule that exempts drug and medical-device companies from having to disclose indirect payments to physicians for accredited continuing medical education could prompt manufacturers to shift their marketing dollars toward CME and away from direct promotional programs for their products, experts say.
Obama to Nominate Former P&G Chief McDonald as Next VA Secretary
President Barack Obama plans to nominate former Procter & Gamble CEO and West Point graduate Robert McDonald as the next Veterans Affairs secretary.
Calorie Restriction Could Help Outcomes in Triple Negative Breast Cancer
Caloric restriction in women with the triple negative disease was found to reduce incidence of metastases in a pre-clinical model.
Equal Benefit from Cetuximab and Bevacizumab in mCRC
For patients with KRAS wild-type untreated colorectal cancer, adding cetuximab or bevacizumab to combination chemotherapy offers equivalent survival, researchers said at the ESMO 16th World Congress on Gastrointestinal Cancer in Barcelona
Cost Deters Medicaid Expansion
Medicaid expansion continues to vary in popularity. Twenty-six states and the District of Columbia plan to expand Medicaid, while 4 are actively considering it and 20 have no plans to do so.
CHMP Recommends Avastin with Chemotherapy in Women with Platinum-Resistant Ovarian Cancer
Avastin is the first biologic medicine to receive a CHMP positive opinion for the most difficult to treat form of ovarian cancer.
Diabetes Care “Bundle” Produces Better Health Outcomes, AJMC Study Finds
Geisinger Health System’s use of a diabetes care system among high-risk patients produced lower risks of myocardial infarction, stroke and retinopathy over a three-year period, according to a study in The American Journal of Managed Care. Best of all, most of the benefit accrued in the first year of care.
Vaccine Could Boost Immune Attack Against Brain Tumors?
Scientists in Germany have developed a vaccine that they say provides some protection against brain tumors in mice.
Study Finds Low-Dose Aspirin Can Reduce the Risk of Pancreatic Cancer
The longer a person took low-dose aspirin, the lower his or her risk for developing pancreatic cancer, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
Correcting The Blind Spot In Accountability: The Role Of Pharmacy Care
CMS stated that they seek recommendations about how the ACO program might evolve to “encourage greater care integration and financial accountability.”
Wearable Devices, mHealth Can Lead to True Patient Engagement
Smart watches, mHealth apps, and Bluetooth scales may just be edging into the social consciousness as a viable way to monitor personal health and manage chronic diseases, but EHR developers have been eyeing these technologies for some time, seeing them as valuable tools in the struggle to engage patients, prevent unnecessary readmissions, reduce costs, and promote long-term health.
Hospital Outpatient Prices Sharply Higher than Docs', Study Finds
Hospital outpatient prices for standard blood tests, cancer screening and other services varied widely and were sharply higher, on average, than prices charged by ambulatory clinics and independent doctors, an analysis of autoworker health-plan spending across 18 cities has found.
FDA Panel Wants More Data for Astra's Olaparib
Safety concerns over the PARP inhibitor warranted the request for additional data.
Transitioning to Bundled Payments
Taking a more strategic approach to payer relationships may be the key to surviving new reimbursements models.
AJAC Highlights Potential of Connected Care, Patient-Centered Ways to Measure Quality
The June issue of The American Journal of Accountable Care discusses the potential of “connected care,” to improve access and cut costs, and proves how what patients say will matter when measuring quality. The publication, from The American Journal of Managed Care, is devoted to research and commentary on healthcare reform.
In Push to Extend Medicaid Pay Bump, Docs Downplay ACA Link
Physician groups are lobbying hard to extend an Obamacare provision that requires state Medicaid programs to pay primary-care physicians at higher Medicare rates to improve access for Medicaid patients. But to persuade congressional Republicans to go along, they are downplaying the fact that the pay bump is part of the Patient Protection and Affordable Care Act.
Nivolumab Trial Halted Early: Promising Phase 3 Results in Advanced Melanoma
Results indicate that nivolumab is likely to prolong survival in advanced melanoma.